Shuman Li
Papers
1
Total Citations
12
H-Index
1
About
Shuman Li is a leading surgical oncologist whose research focuses on optimizing treatment strategies for rectal cancer, particularly through the integration of neoadjuvant chemoradiotherapy (nCRT) with advanced surgical techniques. Dr. Li’s major contribution lies in the comparative effectiveness of open, laparoscopic, and robotic surgery following nCRT, as demonstrated in their landmark 2019 Bayesian network meta-analysis. This work, which has garnered 12 citations, systematically synthesized short- and long-term outcomes from randomized controlled trials, providing crucial evidence that helps surgeons select the most beneficial approach for patients. By employing rigorous statistical methods to compare these three modalities, Dr. Li has clarified the trade-offs between recovery times, complication rates, and oncologic results. Their research directly informs clinical decision-making in a field where surgical precision and patient quality of life are paramount. Dr. Li’s work is essential reading for any clinician or researcher navigating the evolving landscape of multimodal rectal cancer treatment, highlighting a commitment to evidence-based surgery that improves patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1